| P50 | author | Eric A Macklin | Q45310572 |
| | Joshua L Roffman | Q47502175 |
| | Jordan W Smoller | Q57394220 |
| | Donald C Goff | Q90481276 |
| P2093 | author name string | David G Brohawn | |
| | Adam Z Nitenson | |
| P2860 | cites work | Genetics of human neural tube defects | Q22337140 |
| | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
| | Epigenomic profiling reveals DNA-methylation changes associated with major psychosis | Q24655403 |
| | Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 |
| | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 |
| | Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database | Q28285397 |
| | The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 |
| | Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase | Q28512009 |
| | Personal genomes: The case of the missing heritability | Q29614582 |
| | Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia | Q31036338 |
| | In vivo NMR measures of NAA and the neurobiology of schizophrenia | Q31046915 |
| | Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia | Q33815618 |
| | Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 |
| | Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia | Q34004490 |
| | A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. | Q34025724 |
| | Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond | Q34494146 |
| | Folate, homocysteine, and negative symptoms in schizophrenia | Q34550533 |
| | From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia | Q34977902 |
| | Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review | Q35672899 |
| | The role of one-carbon metabolism in schizophrenia and depression | Q36905614 |
| | MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. | Q36970899 |
| | Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen | Q37265182 |
| | Elevated prenatal homocysteine levels as a risk factor for schizophrenia | Q38434683 |
| | Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population | Q39411356 |
| | No Association Between Functional Polymorphisms in COMT and MTHFR and Schizophrenia Risk in Korean Population | Q41568991 |
| | Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia | Q42166996 |
| | Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility | Q42649179 |
| | A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk | Q43787664 |
| | Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia | Q44627940 |
| | Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study | Q45204706 |
| | Relationship of cognition and psychopathology to functional impairment in schizophrenia | Q46616400 |
| | Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels | Q46812598 |
| | Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia | Q46815103 |
| | Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging | Q48854560 |
| | Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. | Q51900183 |
| | Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. | Q51927352 |
| | Enhancement of recovery from psychiatric illness by methylfolate. | Q52056334 |
| | Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis. | Q53317307 |
| | Folate supplementation in schizophrenia: A possible role for MTHFR genotype | Q57845812 |
| | Folate levels in psychiatric outpatients | Q73022530 |
| | Schizophrenia | Q73874580 |
| | MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia | Q80118342 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| | metabolic pathway | Q68685 |
| | folic acid | Q127060 |
| | genetic variation | Q349856 |
| P304 | page(s) | 330-338 | |
| P577 | publication date | 2011-10-20 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia | |
| P478 | volume | 39 | |